Collateral for a security interest recorded Sep 22, 2011 (Hercules Technology Growth Capital, Inc.).
Term ends Sep 12, 2035 · High confidence
20-year base term ends Jun 25, 2030
Held by Revance Therapeutics, Inc.
Filed Jun 25, 2010 as application 12/824,118 · Granted May 17, 2016
Base term plus 243 days of patent term adjustment (USPTO delay)
Today
2010
2035
Clock starts
Jun 25, 2010
Jun 25, 2010
Term ends
Sep 12, 2035
Sep 12, 2035
Granted
May 17, 2016
May 17, 2016
base term
patent term adjustment
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
243
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 243 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 25, 2010, when this application, 12/824,118, was filed | Jun 25, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +243 days, USPTO patent term adjustment record | Feb 23, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | +1,662 days, USPTO 35 U.S.C. 156 certificate | added to Feb 23, 2031: Sep 12, 2035 | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 12, 2035 | High confidence |
This family
| US 9,340,587 | this patent Sep 2035 | Sep 2035 |
| US 10,111,939 | In force Jun 2030 | Jun 2030 |
| US 11,351,232 | In force Jun 2030 | Jun 2030 |
| US 11,911,449 | In force Jun 2030 | Jun 2030 |
| Application 18/414,311 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 27, 2010 Reel 24746, frame 319 | Thompson, Stewart A.; Ruegg, Curtis L.; Waugh, Jacob M. | Revance Therapeutics, Inc. | Assignment of Assignor's Interest |
| Sep 22, 2011 Reel 26953, frame 726 | Revance Therapeutics, Inc. | Hercules Technology Growth Capital, Inc. | Security Agreement |
| Sep 27, 2019 Reel 50565, frame 300 | Hercules Capital, Inc. (F/K/A Hercules Technology Growth Capital, Inc.) | Revance Therapeutics, Inc. | Release of Security Interest |
| Mar 18, 2022 Reel 59437, frame 654 | Revance Therapeutics, Inc. | Athyrium Buffalo LP | Security Interest |
| Feb 7, 2025 Reel 70153, frame 630 | Athyrium Buffalo LP | Revance Therapeutics, Inc. | Release of Security Interest |
| Feb 7, 2025 Reel 70153, frame 663 | Revance Therapeutics, Inc.; Crown Laboratories, Inc. | Hayfin Services LLP, as Administrative Agent | Security Interest |
| Feb 7, 2025 Reel 70153, frame 736 | Revance Therapeutics, Inc.; Bellus Medical, LLC; Crown Laboratories, Inc. | Hayfin Services LLP, as Administrative Agent | Security Interest |
| Feb 17, 2025 Reel 70239, frame 739 | Revance Therapeutics, Inc. | Jpmorgan Chase Bank, N.a. | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2035
Term ends Sep 12, 2035. Maintenance fees still fall due before then
Note
The 243 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
36
later US patents cite this one
That is top 25% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.